Levetiracetam Evolugen (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A in the brain, which modulates the release of neurotransmitters. By stabilising neuronal firing and limiting excessive excitatory signals, it lowers the chance of seizure initiation and spread.

The specific dosage of Levetiracetam Evolugen is determined by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Only a qualified healthcare professional should set the appropriate dose.

Safety data for levetiracetam in pregnancy are limited, and the drug is classified as having an unknown pregnancy category. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider.

To request Levetiracetam Evolugen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam is distinguished by its unique SV2A binding mechanism, which generally results in fewer drug‑drug interactions compared with enzyme‑inducing antiepileptics such as carbamazepine. It is often chosen for its broad spectrum of activity and relatively favorable tolerability profile.

Levetiracetam Evolugen should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing in high‑humidity environments.

Levetiracetam Evolugen is taken orally, usually as a tablet. It can be swallowed whole with water, and may be taken with or without food according to the prescriber’s instructions.

Serious risks include severe allergic reactions, Stevens‑Johnson syndrome, suicidal thoughts or behaviors, and significant mood changes such as depression. Patients should seek immediate medical attention if they notice rash, swelling, mood disturbances, or thoughts of self‑harm.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Patients with severe renal impairment may require dose adjustment, and those with a history of serious psychiatric disorders should be closely monitored.